life scienc tool diagnost compani updat
boost ep guid high-end rang stronger revenu growth
expect ep high-end target
rang ex dental vs estim driven stronger core revenu growth
bp higher previou guidanc ex dental led strength across
life scienc pall biotech diagnost cepheid rais ep
reflect robust core revenu run-rat
pend ge biopharma deal updat re-affirmed expect close ge
biopharma deal remain posit bias pend acquisit
dhr focu enhanc exposur life science/diagnost arena sinc
spin-off clearli pay demonstr
acceler organ growth trajectori remind make signific
stride toward deal close particularli follow eu commiss recent condit
approv subject divestitur variou small busi unit across life
scienc platform repres million revenu see eu condit
approv in-lin expect line expect
reiter outperform share vs
confid near long-term growth prospect increas exposur faster-
grow end-market particularli aforement pend acquisit
biopharma busi recent spin-off envista hold neutral
initi note formerli dentalco septemb moreov continu
expand exposur recur revenu stream revenu vs year
ago also opportun healthi innov pipelin runway margin improv
capit deploy risk includ util macro condit miscu
report ep januari estimate confer call
valuat metric
number share
 close
legal entiti disclosur statu non-u analyst us disclosur credit suiss seek busi
compani cover research report result investor awar firm may conflict interest could
affect object report investor consid report singl factor make invest decis
profit tax
chang work capit
flow oper
free cash-flow firm
flow invest
chang net cash/debt
total liabil equiti
share wtd average
price book
roe stated-return
lead manufactur system instrument
consum broad array purpos custom primari
dental environment health/appli scienc
blue sky scenario assum signific acceler
key end market global signific rebound dental trend better
expect implement db acquir compani market
share gain materi margin expans
grey sky scenario base signific weak
key end market prolong weak dental demand trend
deceler core growth acquisit integr headwind
 close
compani mention price
erin wilson wright certifi view express report accur reflect person view subject compani
secur part compens directli indirectli relat specif recommend view
express report
